# Clinical Decision-making, Prognosis, Quality of Life and Satisfaction in Relapsed/Refractory Multiple Myeloma

> **NCT03190525** · — · ACTIVE_NOT_RECRUITING · sponsor: **Gruppo Italiano Malattie EMatologiche dell'Adulto** · enrollment: 530 (estimated)

## Conditions studied

- Multiple Myeloma

## Interventions

- **OTHER:** Quality of life questionnaires

## Key facts

- **NCT ID:** NCT03190525
- **Lead sponsor:** Gruppo Italiano Malattie EMatologiche dell'Adulto
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2017-11-13
- **Primary completion:** 2025-12
- **Final completion:** 2025-12
- **Target enrollment:** 530 (ESTIMATED)
- **Last updated:** 2025-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03190525

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03190525, "Clinical Decision-making, Prognosis, Quality of Life and Satisfaction in Relapsed/Refractory Multiple Myeloma". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03190525. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*